Profound Research

Home
United States
Nashville, TN
Profound Research

Connecting patients and physicians to advanced therapeutic options through clinical research.

02/20/2026

Today we observe National Caregivers Day, and recognize the professional and family caregivers who provide essential care, comfort, and support every day.

Caregivers show up in many forms: nurses, home health aides, and hospice professionals; parents, partners, adult children, and friends. Whether in a clinical setting or at home, their work requires patience, resilience, and extraordinary compassion.

At Profound Research, we see firsthand how deeply connected caregiving is to clinical research. Caregivers support patients through diagnosis, treatment, and recovery, and their advocacy, and participation help advance the therapies of tomorrow. The relationship between those who provide care, those who receive it, and those working to develop new treatments is inseparable.

To caregivers everywhere, we say thank you! Your work matters more than words can express.

02/16/2026

Handle high blood pressure with care

The ZENITH clinical research study for people with uncontrolled high blood pressure aims to find out if an

investigational medication can help lower the risk of cardiovascular events, such as heart attack and stroke

Are you living with high blood pressure?

You may be able to take part.

https://profoundresearch.com/study/aln-agt01-008?source=metaorganic

02/13/2026

This week we recognized the International Day of Women and Girls in Science, and we’re committed to continuing that recognition year-round.

At Profound Research, we celebrate the women across our organization, from research coordinators and principal investigators to clinical operations leaders, data specialists, and those in leadership roles. Your expertise and dedication are crucial to the advancement of clinical research and expanded access to innovative therapies.

Scientific progress doesn’t happen in isolation. It happens because of curiosity, persistence, mentorship, and collaboration, and because women continue to lead, question, build, and inspire at every level.

To the women shaping the future of science at Profound and across our industry, and to the girls imagining what’s possible tomorrow, thank you.

02/09/2026

50% of all heart failure patients are iron deficient.

This could be you, and you could be qualified for the ICONIC-HF study.

The ICONIC-HF study is testing intravenous iron as an investigational treatment to see if it helps improve symptoms and reduce hospitalizations in participants who have heart failure and iron deficiency.

𝗬𝗼𝘂 𝗺𝗮𝘆 𝗯𝗲 𝗮𝗯𝗹𝗲 𝘁𝗼 𝗷𝗼𝗶𝗻 𝘁𝗵𝗲 𝗜𝗖𝗢𝗡𝗜𝗖-𝗛𝗙 𝘀𝘁𝘂𝗱𝘆 𝗶𝗳 𝘆𝗼𝘂:

• Are at least 18 years old. (Both women and men can join.)

• Have heart failure that causes fatigue, shortness of breath, or other symptoms.

• Have left ventricle (chamber) ejection fraction (pumping ability) that is 45% or less.

Other requirements need to be met to join the ICONIC-HF study. Please contact us for details.

𝗜𝗳 𝘆𝗼𝘂 𝗾𝘂𝗮𝗹𝗶𝗳𝘆, 𝘆𝗼𝘂 𝗺𝗮𝘆 𝗿𝗲𝗰𝗲𝗶𝘃𝗲 𝘁𝗵𝗲 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗮𝘁 𝗻𝗼 𝗰𝗼𝘀𝘁:

• One or 2 investigational iron infusions given intravenously (or by "IV," meaning through the vein) if you are assigned to the IV iron-infusion group.

• Standard of care for heart failure. (Everyone who qualifies for the study will receive this care.)

• Close medical care and follow-up throughout the study.

• Reimbursement for reasonable study-related expenses like travel and meals.

𝗧𝗮𝗹𝗸 𝘁𝗼 𝘆𝗼𝘂𝗿 𝗱𝗼𝗰𝘁𝗼𝗿 𝘁𝗼 𝘀𝗲𝗲 𝗶𝗳 𝘆𝗼𝘂 𝗾𝘂𝗮𝗹𝗶𝗳𝘆, 𝗼𝗿 𝗰𝗼𝗻𝘁𝗮𝗰𝘁 𝘂𝘀 𝘁𝗼 𝗳𝗶𝗻𝗱 𝗼𝘂𝘁 𝗺𝗼𝗿𝗲:
https://profoundresearch.com/study/pharmacosmos-p-monofer-chf-02?source=metaorganic

California: (619) 489-5613
Michigan: (248) 282-3640
profoundresearch.com

patientinfo@profoundresearch.com

02/02/2026

If you’ve been diagnosed with Atrial Fibrillation or Atrial Flutter within the last year, you may qualify for a research study exploring ways to reduce bleeding risks. Participants receive study-related care and medication at no cost, plus compensation for time and travel. Learn more and see if you’re eligible today.

We are enrolling in an Atrial Fibrillation study that is assessing an investigational medications to see if they can reduce blood clotting without increasing the risk of bleeding in patients with Atrial Fibrillation.

To be eligible to participate, you must:

• Be at least 18 years of age

• Be diagnosed with Atrial Fibrillation or Atrial Flutter within the last year

Additional criteria apply

Qualified participants will receive study-related care and study [medication] at no cost, as well as financial compensation for time and travel expenses. Fill out the contact form and we’ll be in touch soon with more information.

https://profoundresearch.com/study/r7508-cva-2393?source=facebook

01/19/2026

Today, we honor the legacy of Dr. Martin Luther King Jr. and his enduring commitment to equality, justice, and compassion.

In observance of Martin Luther King Jr. Day, our offices will be closed on Monday, January 19th as we encourage time for rest, reflection, and service in the spirit of Dr. King’s vision.

11/06/2025

COVID Vaccine Study Needs Volunteers in Oceanside, CA and Farmington Hills, MI - Sign up today at https://bit.ly/3Wxl1F7

Take part in a new COVID vaccine research study today and help advance healthcare for tomorrow. To qualify, you must be 50-84 years of age and unvaccinated or previously vaccinated with a COVID vaccine more than 90 days ago. Participants receive investigational vaccine and study-related care at no cost as well as compensation for time and travel.

10/27/2025

A new primary hypothyroidism study is taking place in your area. We need volunteers who have underactive thyroid to help our doctors learn more about an investigational treatment. You may be compensated for time and travel. Learn more: https://bit.ly/43Aqv4N

10/20/2025

Living with COPD can be difficult. Doctors in your area are looking for ways to improve symptoms. See if you qualify for a new clinical study: https://bit.ly/4qp8rWe. Compensation for time is available.

10/06/2025

If you or a loved one have type 1 diabetes, consider taking part in a new clinical study to see how a weekly insulin helps in reducing blood sugar. Participate at no cost. Up to $3,600 for time and travel. Find out more today: https://bit.ly/42XLS0u

09/29/2025

Are you being treated for heart failure (HF)? The EASi-HF Reduced Trial is looking at an investigational treatment option for people with chronic HF. This investigational treatment option is a combination of an investigational medication with an approved medication for HF. If you are 18 years of age or older, and are being treated for HF that was diagnosed at least 3 months ago, you might be able to participate. Please contact us to find out more about the trial: http://bit.ly/46r34xI

09/15/2025

Take part in a new flu prevention research study today and help advance healthcare for tomorrow. Learn more: https://bit.ly/4mmysCe

Address

1213 5th Avenue North
Nashville, TN
32708

Website

https://profoundresearch.io/

Alerts

Be the first to know and let us send you an email when Profound Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your practice to be the top-listed Clinic in Nashville?